SEVION THERAPEUTICS
Sevion is a biopharmaceutical company which discovers, develops and acquires innovative product candidates for the treatment of cancer and immunological diseases. The Company is advancing a pipeline of proprietary and partnered product candidates that leverages its unique antibody technology platforms. The Company’s antibody pipeline is being developed from technology that allows for the discovery of innovative biologic therapies to previously inaccessible targets, such as multispanning membrane proteins and ion channels that play an important role in multiple diseases. The Company also developed the first protein nanocage system allowing delivery of nucleic acids and other payloads to target cells.
SEVION THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
1964-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.seviontherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
(858) 909-0749
Email Addresses:
[email protected]
Total Funding:
16.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Font Awesome CloudFront OpenResty ThemePunch AWS Global Accelerator AdBlock Acceptable Ads
Current Employees Featured
Founder
Stock Details
Investors List
The Hewlett Fund
The Hewlett Fund investment in Post-IPO Equity - Sevion Therapeutics
Defiance Capital
Defiance Capital investment in Post-IPO Equity - Sevion Therapeutics
Whalehaven Capital Fund
Whalehaven Capital Fund investment in Post-IPO Equity - Sevion Therapeutics
InterGroup
InterGroup investment in Post-IPO Equity - Sevion Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Sevion Therapeutics
Next View Partners
Next View Partners investment in Post-IPO Equity - Sevion Therapeutics
Midsummer Capital
Midsummer Capital investment in Post-IPO Equity - Sevion Therapeutics
Northern Rivers Capital Management
Northern Rivers Capital Management investment in Post-IPO Equity - Sevion Therapeutics
Alpha Capital
Alpha Capital investment in Post-IPO Equity - Sevion Therapeutics
Iroquois Capital
Iroquois Capital investment in Post-IPO Equity - Sevion Therapeutics
Official Site Inspections
http://www.seviontherapeutics.com
- Host name: 172.67.142.77
- IP address: 172.67.142.77
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
